title: Clofarabine as a potential stimulant of alloreactivity.
authors.forename: N
authors.initials: N
authors.lastname: Atimere
authors.forename: S
authors.initials: S
authors.lastname: Zriba
authors.forename: Y
authors.initials: Y
authors.lastname: Hicheri
authors.forename: C
authors.initials: C
authors.lastname: Pautas
authors.forename: C
authors.initials: C
authors.lastname: Cordonnier
authors.forename: S
authors.initials: S
authors.lastname: Maury
mesh_terms: D000227:Adenine Nucleotides / Q000008:administration & dosage*; D001087:Arabinonucleosides / Q000008:administration & dosage*; D000077866:Clofarabine; D005260:Female; D006086:Graft vs Host Disease; D020544:Graft vs Leukemia Effect / Q000187:drug effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008875:Middle Aged; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery; D014181:Transplantation Immunology / Q000187:drug effects*
chemical_list: D000227:Adenine Nucleotides; D001087:Arabinonucleosides; D000077866:Clofarabine